title: [Carbonic anhydrase inhibitors and calcium phosphate stones].
authors.affiliation: Division de néphrologie, Centre hospitalier universitaire vaudois, Lausanne, Suisse. Frederic.Barbey@chuv.hospvd.ch
authors.forename: F
authors.initials: F
authors.lastname: Barbey
authors.forename: G
authors.initials: G
authors.lastname: Nseir
authors.forename: C
authors.initials: C
authors.lastname: Ferrier
authors.forename: M
authors.initials: M
authors.lastname: Burnier
authors.forename: M
authors.initials: M
authors.lastname: Daudon
mesh_terms: D000086:Acetazolamide / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D002130:Calcium Phosphates / Q000032:analysis*; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004421:Dystonia / Q000188:drug therapy; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced* / Q000737:chemistry*
chemical_list: D002130:Calcium Phosphates; D002257:Carbonic Anhydrase Inhibitors; D000086:Acetazolamide
vernacular_title: Inhibiteurs de l'anhydrase carbonique et lithiase urinaire phosphocalcique.